{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:10:45Z","timestamp":1792797045563,"version":"4.5.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Alcohol-associated liver disease (ALD), a significant cause of chronic liver disease worldwide, is strongly linked to gut microbiome dysregulation. Heavy alcohol use disrupts the gut bacterial equilibrium and damages the intestinal barrier, making it more permeable to microbial toxins (e.g., endotoxins) that trigger liver inflammation. Many studies have investigated ALD, but no single microbial marker has yet been identified as diagnostic. Results from microbiome studies on this condition have been inconsistent; consequently, scientists are developing new microbiome-based indices and multi-omics approaches to improve their ability to predict diseases. The review evaluates current findings on how disturbances in the gut microbiome and deterioration of the intestinal barrier contribute to the development of ALD. The assessment includes microbiome-based treatments such as probiotics, fecal microbiota transplantation (FMT), and bacteriophage therapy. Research indicates that probiotics and FMT treatments may enhance liver function and reduce inflammation in patients with ALD. The studies present conflicting results because researchers used different methods and worked with limited numbers of participants. Bacteriophage therapy exists as an experimental treatment method. The development of personalized microbiome treatments, along with biomarker standardization and solutions to technical and ethical challenges, will enable these strategies to enter medical practice. The review integrates existing knowledge of the gut-liver axis in ALD to demonstrate the clinical potential of microbiome-based treatments while highlighting the need for additional research to enhance treatment outcomes.<\/jats:p>","DOI":"10.3389\/fphar.2026.1770833","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:01:24Z","timestamp":1775019684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut microbiome in alcohol-associated liver disease: interactions and therapeutic strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Xianting","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"He","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuting","family":"Wu","sequence":"additional","affiliation":[{"name":"Basic Medical College, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third People\u2019s Hospital of Chengdu","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.3350\/cmh.2024.0709","article-title":"Alcohol-associated liver disease: natural history, management and novel targeted therapies","volume":"31","author":"Alvarado-Tapias","year":"2025","journal-title":"Clin. Mol. Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"104033","DOI":"10.1016\/j.ebiom.2022.104033","article-title":"Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: a pilot randomized, double-blind, placebo-controlled study","volume":"80","author":"Amadieu","year":"2022","journal-title":"Ebiomedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.3390\/ijms26157345","article-title":"Autobrewery syndrome and endogenous ethanol production in patients with MASLD: a perspective from chronic liver disease","volume":"26","author":"Andaloro","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"goae097","DOI":"10.1093\/gastro\/goae097","article-title":"Advances in the management of alcohol-associated liver disease","volume":"12","author":"Anouti","year":"2024","journal-title":"Gastroenterol. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41575-021-00527-0","article-title":"Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation","volume":"19","author":"Arab","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-0042-1755272","article-title":"Unraveling the complexity of liver disease one cell at a time","volume":"42","author":"Atif","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jceh.2022.02.001","article-title":"Current medical treatment for alcohol-associated liver disease","volume":"12","author":"Ayares","year":"2022","journal-title":"J. Clin. Exp. Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/hep.29760","article-title":"Gut-liver axis alterations in alcoholic liver disease: are bile acids the answer?","volume":"67","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J. Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/s0168-8278(20)30660-7","article-title":"Fecal microbial transplant reduces short-term cravings, improves quality of life and microbial diversity in cirrhosis and alcohol use disorder: a randomized, placebo-controlled, clinical trial","volume":"73","author":"Bajaj","year":"2020","journal-title":"J. Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A randomized clinical trial of fecal microbiota transplant for alcohol use disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","article-title":"Promises of microbiome-based therapies","volume":"76","author":"Bajaj","year":"2022","journal-title":"J. Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1372755","DOI":"10.3389\/fnut.2024.1372755","article-title":"Probiotics-role in alleviating the impact of alcohol liver disease and alcohol deaddiction: a systematic review","volume":"11","author":"Bernhardt","year":"2024","journal-title":"Front. Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2300023","DOI":"10.1002\/pmic.202300023","article-title":"Multi-omics approach to socioeconomic disparity in metabolic syndrome reveals roles of diet and microbiome","volume":"23","author":"Bishehsari","year":"2023","journal-title":"Proteomics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1215333","DOI":"10.3389\/fimmu.2023.1215333","article-title":"NLRP3: a new therapeutic target in alcoholic liver disease","volume":"14","author":"Brahadeeswaran","year":"2023","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/hep.0000000000000324","article-title":"IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice","volume":"78","author":"Cabr\u00e9","year":"2023","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.dld.2023.10.006","article-title":"Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity","volume":"56","author":"Calzadilla","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.3390\/ijms24054344","article-title":"Single-cell RNA transcriptome profiling of liver cells of short-term alcoholic liver injury in mice","volume":"24","author":"Cao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1717696","DOI":"10.3389\/fcimb.2025.1717696","article-title":"Gut microbiome and its metabolites in liver cirrhosis: mechanisms and clinical implications","volume":"15","author":"Chang","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"840752","DOI":"10.3389\/fmed.2022.840752","article-title":"The role of gut bacteria and fungi in alcohol-associated liver disease","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/microorganisms11051181","article-title":"The novel role of phage particles in chronic liver diseases","volume":"11","author":"Chen","year":"","journal-title":"Microorganisms"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/jgh.16282","article-title":"Alcohol and the mechanisms of liver disease","volume":"38","author":"Chen","year":"","journal-title":"J. Gastroenterology Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/00952990.2024.2402569","article-title":"Exploring the impact of inflammatory cytokines on alcoholic liver disease: a Mendelian randomization study with bioinformatics insights into potential biological mechanisms","volume":"50","author":"Chen","year":"2024","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jare.2024.07.002","article-title":"The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD","volume":"72","author":"Cheng","year":"2025","journal-title":"J. Adv. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2297860","DOI":"10.1080\/19490976.2023.2297860","article-title":"Multi-omic approaches for host-microbiome data integration","volume":"16","author":"Chetty","year":"2024","journal-title":"Gut Microbes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/tgh.2019.09.06","article-title":"Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)","volume":"6","author":"Choudhary","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J. Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/antiox11071258","article-title":"Ethanol metabolism in the liver, the induction of oxidant stress, and the antioxidant defense","volume":"11","author":"Contreras-Zentella","year":"2022","journal-title":"System"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1292673","DOI":"10.3389\/fphys.2023.1292673","article-title":"A systematic review on the effects of exercise on gut microbial diversity, taxonomic composition, and microbial metabolites: identifying research gaps and future directions","volume":"14","author":"Cullen","year":"2023","journal-title":"Front. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep4.1793","article-title":"The integrated \u201cmultiomics\u201d landscape at peak injury and resolution from alcohol-associated liver disease","volume":"6","author":"Das","year":"2022","journal-title":"Hepatol. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.14218\/jcth.2024.00257","article-title":"Decoding 17-Beta-hydroxysteroid dehydrogenase 13: a multifaceted perspective on its role in hepatic steatosis and associated disorders","volume":"12","author":"Demirtas","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1054685","DOI":"10.3389\/fpsyt.2022.1054685","article-title":"The diversity of the intestinal microbiota in patients with alcohol use disorder and its relationship to alcohol consumption and cognition","volume":"13","author":"Du","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.3390\/ijms24043735","article-title":"Alcohol, inflammation, and microbiota in alcoholic liver disease","volume":"24","author":"Duki\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1097\/hep.0000000000000883","article-title":"An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: a global cohort study","volume":"80","author":"Dunn","year":"2024","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e35008","DOI":"10.1371\/journal.pone.0035008","article-title":"Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model","volume":"7","author":"Elamin","year":"2012","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100220","DOI":"10.1016\/j.jhepr.2020.100220","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"Jhep Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3724\/abbs.2024074","article-title":"Development of an alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell-derived liver organoids","volume":"56","author":"Feng","year":"2024","journal-title":"Acta Biochimica Biophysica Sinica"},{"key":"B40","doi-asserted-by":"publisher","first-page":"S1467","DOI":"10.14309\/01.ajg.0001037580.02027.fb","article-title":"Targeted breath biopsy profiling of induced biomarkers unveils a metabolic adaptation in cirrhosis toward alcohol production","volume":"119","author":"Ferrandino","year":"2024","journal-title":"Am. J. Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.jhepr.2023.100909","article-title":"Phage therapy: targeting intestinal bacterial microbiota for the treatment of liver diseases","volume":"5","author":"Fujiki","year":"2023","journal-title":"JHEP Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e16211","DOI":"10.1111\/liv.16211","article-title":"PNPLA3 in alcohol-related liver disease","volume":"45","author":"Galvanin","year":"2025","journal-title":"Liver Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3350\/cmh.2022.0171","article-title":"Microbiome and metabolomics in alcoholic liver disease","volume":"28","author":"Ganesan","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12072-023-10518-9","article-title":"Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease","volume":"18","author":"Ganesan","year":"2024","journal-title":"Hepatol. Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics8030131","article-title":"Phage therapy with a focus on the human microbiota","volume":"8","author":"Ganeshan","year":"2019","journal-title":"Antibiotics-Basel"},{"key":"B46","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/metabo11110766","article-title":"Integrative analysis of metabolome and microbiome in patients with progressive alcohol-associated liver disease","volume":"11","author":"Gao","year":"2021","journal-title":"Metabolites"},{"key":"B47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/metabo12010041","article-title":"Machine learning applied to omics datasets predicts mortality in patients with alcoholic hepatitis","volume":"12","author":"Gao","year":"2022","journal-title":"Metabolites"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e100104","DOI":"10.1136\/egastro-2024-100104","article-title":"Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease","volume":"2","author":"Gao","year":"2024","journal-title":"eGastroenterology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1522401","DOI":"10.3389\/fbinf.2025.1522401","article-title":"Biomarker-driven drug repurposing for NAFLD-Associated hepatocellular carcinoma using machine learning integrated ensemble feature selection","volume":"5","author":"Ghosh","year":"","journal-title":"Front. Bioinforma."},{"key":"B50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gutjnl-2023-331740","article-title":"Artificial intelligence applied to \u2018omics data in liver disease: towards a personalised approach for diagnosis","volume":"74","author":"Ghosh","year":"","journal-title":"Prognosis Treatment"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as supportive treatment in liver diseases: a narrative review","volume":"37","author":"Gillessen","year":"2020","journal-title":"Adv. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jceh.2021.12.016","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"J. Clin. Exp. Hepatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/acer.15338","article-title":"The gut microbiome in alcohol use disorder and alcohol-associated liver disease: a systematic review of clinical studies","volume":"48","author":"Grodin","year":"2024","journal-title":"Alcohol-Clinical Exp. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1111\/liv.70119","article-title":"Surrogate markers of intestinal permeability, bacterial translocation and gut-vascular barrier damage across stages of cirrhosis","volume":"45","author":"Haedge","year":"2025","journal-title":"Liver Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1038\/s41467-025-60755-9","article-title":"The postbiotic ReFerm\u00ae versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial","volume":"16","author":"Hansen","year":"2025","journal-title":"Nat. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","article-title":"Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice","volume":"68","author":"Hendrikx","year":"2019","journal-title":"Gut"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2471127","DOI":"10.1080\/15592294.2025.2471127","article-title":"Single and multi-omic characterization of a porcine model of ethanol-induced hepatic fibrosis","volume":"20","author":"Hieromnimon","year":"2025","journal-title":"Epigenetics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"23001","DOI":"10.1038\/s41598-023-49505-3","article-title":"Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites","volume":"13","author":"H\u00f6ppner","year":"2023","journal-title":"Sci. Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/hep4.1947","article-title":"Intestinal virome in patients with alcohol use disorder and after abstinence","volume":"6","author":"Hsu","year":"2022","journal-title":"Hepatol. Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1097\/hep.0000000000000238","article-title":"Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome","volume":"77","author":"Hsu","year":"2023","journal-title":"Hepatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.3390\/ijms23158749","article-title":"Microbiome-based metabolic therapeutic approaches in alcoholic liver disease","volume":"23","author":"Hyun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.3390\/jcm14175981","article-title":"Fecal microbiota transplantation in patients with alcohol-associated cirrhosis: a clinical trial","volume":"14","author":"Ichim","year":"2025","journal-title":"J. Clin. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jceh.2022.07.246","article-title":"Emerging biomarkers in alcohol-associated hepatitis","volume":"13","author":"Im","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J. Gastroenterology Hepatology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000535962","article-title":"Exploring the relationship between liver disease, bacterial translocation, and dysbiosis: unveiling the gut-liver axis","volume":"40","author":"Juanola","year":"2024","journal-title":"Visc. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"913842","DOI":"10.3389\/fmed.2022.913842","article-title":"Gut microbiota-modulating agents in alcoholic liver disease: links between host metabolism and gut microbiota","volume":"9","author":"Jung","year":"2022","journal-title":"Front. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"869250","DOI":"10.3389\/fmicb.2022.869250","article-title":"Probiotic lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00394-025-03668-z","article-title":"Associations of alcohol with the human gut microbiome and prospective health outcomes in the FINRISK 2002 cohort","volume":"64","author":"Koponen","year":"2025","journal-title":"Eur. J. Nutr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.14798","article-title":"Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival","volume":"1514","author":"Kuo","year":"2022","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1111\/jgh.17038","article-title":"Compositional and metabolomic shifts of the gut microbiome in alcohol-related liver disease","volume":"40","author":"Kuo","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"","journal-title":"Gastroenterology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.30832\/suppinfo","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"","journal-title":"Hepatology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1785251","DOI":"10.1080\/19490976.2020.1785251","article-title":"Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients","volume":"12","author":"Lang","year":"","journal-title":"Gut Microbes"},{"key":"B76","doi-asserted-by":"publisher","first-page":"6621644","DOI":"10.1155\/2021\/6621644","article-title":"Plant-based foods and their bioactive compounds on Fatty liver disease: effects, mechanisms, and clinical application","volume":"2021","author":"Li","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/biomedicines13010074","article-title":"Gut Microbiota as emerging players in the development of alcohol-related liver disease","volume":"13","author":"Li","year":"2024","journal-title":"Biomedicines"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.62347\/ldch9386","article-title":"Gut microbiota dysbiosis in alcoholic fatty liver disease: distinct microbial communities and biochemical alterations","volume":"17","author":"Li","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0000447","DOI":"10.1371\/journal.pdig.0000447","article-title":"Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning","volume":"3","author":"Listopad","year":"2024","journal-title":"PLOS Digit. Health"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e2300927","DOI":"10.1002\/mnfr.202300927","article-title":"Postbiotics prepared using Lactobacillus reuteri ameliorates ethanol-induced liver injury by regulating the FXR\/SHP\/SREBP-1c axis","volume":"68","author":"Liu","year":"","journal-title":"Mol. Nutr. and Food Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"110735","DOI":"10.1016\/j.humimm.2023.110735","article-title":"Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis","volume":"85","author":"Liu","year":"","journal-title":"Hum. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/a-1714-9246","article-title":"Inflammation in alcohol-associated liver disease progression","volume":"60","author":"Lotersztajn","year":"2022","journal-title":"Z Gastroenterol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11901-025-00703-9","article-title":"Alcohol-Associated hepatitis: translating pathophysiology into targeted clinical trials","volume":"24","author":"Ma","year":"","journal-title":"Curr. Hepatol. Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"105089","DOI":"10.3748\/wjg.v31.i28.105089","article-title":"Fecal microbiota transplantation: a promising treatment strategy for chronic liver disease","volume":"31","author":"Ma","year":"","journal-title":"World J. Gastroenterology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes"},{"key":"B86","doi-asserted-by":"publisher","first-page":"A5","DOI":"10.1136\/gutjnl-2021-BASL.9","article-title":"A double blind, randomised, placebo-controlled study to assess safety and tolerability of oral enterosorbent carbalive (YAQ-001) in cirrhotic patients","volume":"70","author":"Macnaughtan","year":"2021","journal-title":"Gut"},{"key":"B87","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13099-025-00703-6","article-title":"Thomasclavelia ramosa and alcohol-related hepatocellular carcinoma: a microbial culturomics study","volume":"17","author":"Magdy Wasfy","year":"2025","journal-title":"Gut Pathog."},{"key":"B88","doi-asserted-by":"publisher","first-page":"goae069","DOI":"10.1093\/gastro\/goae069","article-title":"Current epidemiology of chronic liver disease","volume":"12","author":"Manikat","year":"2024","journal-title":"Gastroenterol. Rep. (Oxf)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/microorganisms10051045","article-title":"Trust your gut: the association of gut microbiota and liver disease","volume":"10","author":"Manzoor","year":"2022","journal-title":"Microorganisms"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1038\/s41467-024-49152-w","article-title":"Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice","volume":"15","author":"Mao","year":"2024","journal-title":"Nat. Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/s0168-8278(23)00463-4","article-title":"Plasma multi-omics outlines association of urobilinogen with corticosteroid non-response, inflammation, intestinal permeability and outcome in severe alcoholic hepatitis","volume":"78","author":"Maras","year":"2023","journal-title":"J. Hepatology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/v14030490","article-title":"Immune response of an oral Enterococcus faecalis phage cocktail in a mouse model of ethanol-induced liver disease","volume":"14","author":"Mendes","year":"2022","journal-title":"Viruses-Basel"},{"key":"B93","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/gastroent14040041","article-title":"Microbiome and genetic factors in the pathogenesis of liver diseases","volume":"14","author":"Miteva","year":"2023","journal-title":"Gastroenterol. Insights"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e0284","DOI":"10.1097\/hc9.0000000000000284","article-title":"Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease","volume":"7","author":"Mrdjen","year":"2023","journal-title":"Hepatol. Commun."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/hep4.1885","article-title":"Development of Alcohol-Associated Hepatitis is associated with specific changes in gut-modified bile acids","volume":"6","author":"Muthiah","year":"2022","journal-title":"Hepatol. Commun."},{"key":"B96","doi-asserted-by":"publisher","first-page":"119328","DOI":"10.1016\/j.lfs.2021.119328","article-title":"A review on molecular mechanism of alcoholic liver disease","volume":"274","author":"Namachivayam","year":"2021","journal-title":"Life Sci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-Acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","article-title":"Noninvasive proteomic biomarkers for alcohol-related liver disease","volume":"28","author":"Niu","year":"2022","journal-title":"Nat. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s2468-1253(19)30452-2","article-title":"Global disparities in faecal microbiota transplantation research","volume":"5","author":"Olesen","year":"2020","journal-title":"Lancet Gastroenterology and Hepatology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1097\/meg.0000000000003003","article-title":"A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis","volume":"37","author":"Pakuwal","year":"2025","journal-title":"Eur. J. Gastroenterology and Hepatology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial","volume":"17","author":"Pande","year":"2023","journal-title":"Hepatol. Int."},{"key":"B102","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/ijms23010426","article-title":"Role of Microbiota-Derived metabolites in alcoholic and non-alcoholic fatty liver diseases","volume":"23","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.1038\/s41598-024-60768-2","article-title":"Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease","volume":"14","author":"Park","year":"2024","journal-title":"Sci. Rep."},{"key":"B104","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jceh.2021.12.016","article-title":"Gut microbiome and alcohol-associated liver disease","volume":"12","author":"Philips","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s40265-023-01939-9","article-title":"Alcohol-Associated liver disease: evolving concepts and treatments","volume":"83","author":"Prince","year":"2023","journal-title":"Drugs"},{"key":"B106","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13099-023-00550-3","article-title":"Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives","volume":"15","author":"Raeisi","year":"2023","journal-title":"Gut Pathog."},{"key":"B107","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/apt.16969","article-title":"Review article: current and emerging therapies for acute alcohol-associated hepatitis","volume":"56","author":"Rattan","year":"2022","journal-title":"Alimentary Pharmacol. and Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1034356","DOI":"10.3389\/fimmu.2023.1034356","article-title":"Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis","volume":"14","author":"Ren","year":"2023","journal-title":"Front. Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","article-title":"Microbiome as a therapeutic target in alcohol-related liver disease","volume":"70","author":"Sarin","year":"2019","journal-title":"J. Hepatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/diseases12040069","article-title":"The role of cytokines in the pathogenesis and treatment of alcoholic liver disease","volume":"12","author":"Scarlata","year":"2024","journal-title":"Diseases"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/pathogens12091087","article-title":"The role of the gastrointestinal microbiome in liver disease","volume":"12","author":"Shalaby","year":"2023","journal-title":"Pathogens"},{"key":"B112","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s12664-023-01420-1","article-title":"A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis","volume":"42","author":"Shankarappa","year":"2023","journal-title":"Indian J. Gastroenterol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol. Int."},{"key":"B114","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3350\/cmh.2020.0057","article-title":"Fecal microbiota transplantation in alcohol related liver diseases","volume":"26","author":"Shasthry","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41423-025-01291-w","article-title":"Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease","volume":"22","author":"Shen","year":"","journal-title":"Cell Mol. Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/mco2.70168","article-title":"Gut Microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"","journal-title":"Medcomm"},{"key":"B117","doi-asserted-by":"publisher","first-page":"109450","DOI":"10.1016\/j.jnutbio.2023.109450","article-title":"Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin","volume":"122","author":"Shibamoto","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1192\/bjb.2025.10129","article-title":"Gut microbiota and alcohol use disorder: a new frontier in treatment and recovery","volume":"50","author":"Skryabin","year":"2025","journal-title":"Bjpsych Bull."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2393272","DOI":"10.1080\/19490976.2024.2393272","article-title":"Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review","volume":"16","author":"Sosnowski","year":"2024","journal-title":"Gut Microbes"},{"key":"B120","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: from biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/hep.31623","article-title":"Phage therapy for alcohol-associated hepatitis","volume":"73","author":"Suh","year":"2021","journal-title":"Hepatology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1292016","DOI":"10.3389\/fcell.2023.1292016","article-title":"Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review","volume":"11","author":"Sun","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1002\/jgh3.70007","article-title":"Impact of fecal microbiota transplantation in severe alcoholic hepatitis: a systematic review and meta-analysis","volume":"8","author":"Taha","year":"2024","journal-title":"Jgh Open"},{"key":"B124","doi-asserted-by":"publisher","first-page":"154410","DOI":"10.1016\/j.prp.2023.154410","article-title":"Role of targeting TLR4 signaling axis in liver-related diseases","volume":"244","author":"Tang","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"B125","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jhep.2024.03.035","article-title":"Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases","volume":"81","author":"Thiele","year":"2024","journal-title":"J. Hepatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","article-title":"The beneficial effects of lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"Vatsalya","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2307586","DOI":"10.1080\/19490976.2024.2307586","article-title":"Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease","volume":"16","author":"Viebahn","year":"2024","journal-title":"Gut Microbes"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1030399","DOI":"10.3389\/fgstr.2022.1030399","article-title":"An update on the genetics of alcoholic liver disease","volume":"1","author":"Vishnubhotla","year":"2022","journal-title":"Front. Gastroenterology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. and Mol. Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1068825","DOI":"10.3389\/fmicb.2022.1068825","article-title":"Alterations and correlations of gut microbiota, fecal, and serum metabolome characteristics in a rat model of alcohol use disorder","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2328521","DOI":"10.1080\/07853890.2024.2328521","article-title":"Global burden of liver cirrhosis 1990-2019 and 20 years forecast: results from the global burden of disease study 2019","volume":"56","author":"Wang","year":"2024","journal-title":"Ann. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1623367","DOI":"10.3389\/fmed.2025.1623367","article-title":"Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.jhepr.2025.101480","article-title":"The alcohol-harm paradox: understanding socioeconomic inequalities in liver disease","volume":"7","author":"Weichselbaum","year":"2025","journal-title":"Jhep Rep."},{"key":"B134","doi-asserted-by":"publisher","first-page":"107752","DOI":"10.1016\/j.pharmthera.2020.107752","article-title":"Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways","volume":"222","author":"Wen","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B135","doi-asserted-by":"publisher","first-page":"01","DOI":"10.35946\/arcr.v44.1.01","article-title":"Gut-liver-brain axis and alcohol use disorder treatment potential of fecal microbiota transplantation","volume":"44","author":"Wolstenholme","year":"2024","journal-title":"Alcohol Research-Current Rev."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1358063","DOI":"10.3389\/fcimb.2024.1358063","article-title":"Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12967-023-04166-8","article-title":"Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease","volume":"21","author":"Yan","year":"2023","journal-title":"J. Transl. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cld.2024.06.008","article-title":"Gut bacteria in alcohol-associated liver disease","volume":"28","author":"Yang","year":"2024","journal-title":"Clin. Liver Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1172\/jci90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest"},{"key":"B140","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.chom.2025.05.003","article-title":"Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease","volume":"33","author":"Yang","year":"2025","journal-title":"Cell Host and Microbe"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1765047","DOI":"10.3389\/fmed.2026.1765047","article-title":"Research advances on gut microbiota dysbiosis and chronic liver diseases: a review","volume":"13","author":"Yang","year":"2026","journal-title":"Front. Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1615839","DOI":"10.3389\/fmed.2025.1615839","article-title":"Gut microbiota in liver diseases: initiation, development and therapy","volume":"12","author":"Yu","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1289356","DOI":"10.3389\/fimmu.2023.1289356","article-title":"Promoting intestinal antimicrobial defense and microbiome symbiosis contributes to IL-22-mediated protection against alcoholic hepatitis in mice","volume":"14","author":"Yue","year":"2023","journal-title":"Front. Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"CD011585","DOI":"10.1002\/14651858.CD011585.pub2","article-title":"Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"7","author":"Zacharias","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e1012377","DOI":"10.1371\/journal.ppat.1012377","article-title":"Gut mycobiome alterations and implications for liver diseases","volume":"20","author":"Zeng","year":"2024","journal-title":"PLoS Pathog."},{"key":"B146","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.chom.2023.02.001","article-title":"Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease","volume":"31","author":"Zeng","year":"2023","journal-title":"Cell Host and Microbe"},{"key":"B147","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.2147\/ijgm.S420195","article-title":"Roles of gut microbiota in alcoholic liver disease","volume":"16","author":"Zhang","year":"","journal-title":"Int. J. General Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1021\/acs.jproteome.3c00093","article-title":"Metabolomics reveals gut microbiota contribute to PPAR\u03b1 deficiency-induced alcoholic liver injury","volume":"22","author":"Zhang","year":"","journal-title":"J. Proteome Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"111852","DOI":"10.1016\/j.intimp.2024.111852","article-title":"Butyrate alleviates alcoholic liver disease-associated inflammation through macrophage regulation and polarization via the HDAC1\/miR-155 axis","volume":"131","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10620-024-08778-y","article-title":"New insights into the pathogenesis of alcoholic liver disease based on global research","volume":"70","author":"Zhang","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"111323","DOI":"10.3748\/wjg.v31.i39.111323","article-title":"Multi-model applications and cutting-edge advancements of artificial intelligence in hepatology in the era of precision medicine","volume":"31","author":"Zheng","year":"2025","journal-title":"World J. Gastroenterology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1714502","DOI":"10.3389\/fimmu.2025.1714502","article-title":"A multi-omics approach combining causal inference and in vivo validation identifies key protein drivers of alcohol-associated liver disease","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Immunol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1258062","DOI":"10.3389\/fphar.2023.1258062","article-title":"Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1770833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:01:27Z","timestamp":1775019687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1770833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":153,"alternative-id":["10.3389\/fphar.2026.1770833"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1770833","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1770833"}}